Abstract
Penetration of cerebrospinal fluid (CSF) by artesunate and DHA was assessed in six adults with cerebral or severe malaria. Lumbar punctures were performed on admission and during convalescence, at 15 min (patient 1), 30 min (patient 2), 45 min (patient 3), 60 min (patient 4), 90 min (patient 5), and 120 min (patient 6) after intravenous administration of 120 mg of artesunate. No artesunate was detectable in CSF. In both studies, DHA levels in CSF increased with time while dihydroartemisinin levels in plasma fell. Dihydroartemisinin might accumulate in CSF during frequent artesunate dosing.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Artemisinins / blood
-
Artemisinins / cerebrospinal fluid*
-
Artemisinins / pharmacokinetics*
-
Artemisinins / therapeutic use
-
Artesunate
-
Chromatography, High Pressure Liquid
-
Female
-
Half-Life
-
Humans
-
Injections, Intravenous
-
Malaria, Cerebral / metabolism*
-
Malaria, Falciparum / drug therapy
-
Malaria, Falciparum / metabolism*
-
Male
-
Middle Aged
-
Sesquiterpenes / blood
-
Sesquiterpenes / cerebrospinal fluid*
-
Sesquiterpenes / pharmacokinetics*
-
Sesquiterpenes / therapeutic use
Substances
-
Artemisinins
-
Sesquiterpenes
-
Artesunate
-
artenimol